Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents

Publication Date: February 1, 2013
Last Updated: March 14, 2022

Key action statements

1. Clinicians must ensure that insulin therapy is initiated for children and adolescents with T2DM who are ketotic or in diabetic ketoacidosis and in whom the distinction between types 1 and 2 diabetes mellitus is unclear and, in usual cases, should initiate insulin therapy for patients
  1. who have random venous or plasma BG concentrations ≥250 mg/dL; or
  2. whose HbA1c is 9%.
(E, Weak)
328602

Overview

Title

Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents

Authoring Organization